BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
BiohacksAI/Targets/CDK14/Compounds

Compounds That Target CDK14

cyclin dependent kinase 14 · 17 compounds in BiohacksAI corpus

CDK14 (cyclin dependent kinase 14) is a protein kinase involved in intracellular signal transduction. Kinases phosphorylate downstream substrates to regulate cell growth, survival, and metabolism. The 17 compounds targeting CDK14 include both pharmaceutical inhibitors and natural compounds with evidence of kinase modulation, ranked by evidence strength from the BiohacksAI corpus.

View CDK14 target page →UniProt: O94921 ↗
Most Studied Compounds for CDK14
1
Sorafenib
300+
studies
2
Indirubin
300+
studies
All 17 Compounds — Ranked by Evidence
1
Alvocidib
4.52
confidence
2
Foretinib
4.34
confidence
3
Bosutinib
4.08
confidence
4
Nintedanib
3.61
confidence
5
Bms 387032
3.47
confidence
6
Fedratinib
3.40
confidence
7
At 7519
3.33
confidence
8
Jnj 7706621
3.09
confidence
9
Lestaurtinib
3.04
confidence
10
Pha 665752
2.71
confidence
11
Kw 2449
2.64
confidence
12
Ast 487
2.56
confidence
13
Su 014813
2.20
confidence
14
Enzastaurin
2.08
confidence
15
Rg 547
2.08
confidence
16
Sorafenib
300+
studies
1.61
confidence
17
Indirubin
300+
studies
0.69
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for CDK14 (cyclin dependent kinase 14). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: CDK14 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.